Most AI product management frameworks are written for consumer software. They assume fast iteration cycles, high user engagement data, A/B testable metrics, and the ability to ship fast and break things. Healthcare breaks every one of those assumptions. Iteration cycles are measured in months because of regulatory review. User engagement data is sparse because clinicians interact with your product for minutes per day, not hours. A/B testing on clinical decisions is ethically complex. And breaking things means patient harm.
After several years building AI products in clinical trials, pharmacovigilance, and hospital operations, I have distilled a set of principles that survive contact with the actual environment. These are not frameworks borrowed from Silicon Valley and applied to healthcare. They are derived from repeated failure in a domain that punishes overconfidence.
Principle 1: Clinical Workflow First, AI Second
The instinct in AI product development is to start with the model capability and then find a clinical problem that fits. This produces technically impressive demos that fail in production. Start instead with a specific clinical workflow: who does what, when, with what information, under what time pressure? Map it with a stopwatch and a notebook, not a survey. The AI opportunity is the gap between what the workflow requires and what the current tools provide. If you cannot articulate exactly where in the workflow your AI changes what a human does, you do not have a product — you have a capability looking for a use case.
Principle 2: Regulatory Is a Feature, Not a Constraint
FDA clearance, CE marking, and HIPAA compliance are typically framed as obstacles that slow development. Reframe them as features. A cleared medical device can charge premium prices, enter hospital formularies, and survive procurement cycles that kill uncleared software. A HIPAA-compliant infrastructure signals to hospital security teams that you have done the work they would otherwise spend 18 months auditing you on. Regulatory investment is competitive moat investment. Build it early, document it properly, and treat it as a first-class product deliverable.
Principle 3: Measure Clinical Outcomes, Not Model Metrics
AUC, F1 score, and accuracy are not clinical outcomes. A model with 95% AUC that does not change what clinicians do has zero clinical value. The relevant metrics are: did time-to-diagnosis change? Did treatment adherence change? Did readmission rate change? These are harder to measure — they require prospective study design, longer time horizons, and often IRB approval. But they are the only metrics that justify the cost and complexity of deploying AI in a clinical environment. If your team cannot state which clinical outcome metric will change if your product works, your product is not ready to be deployed.
Principle 4: The User Is Rarely the Buyer
In consumer software, the user and the buyer are the same person. In healthcare enterprise software, they are almost never the same. The physician uses the product; the CMO and the CFO buy it; the IT team implements it; the compliance team approves it; the nursing staff adapts their workflow around it. Each of these stakeholders has different success criteria and different veto power. A product that physicians love but that IT cannot implement securely, or that finance cannot justify in terms of ROI, will not survive past pilot. Build for the full stakeholder map, not just the end user.
Principle 5: Trust Compounds Slowly and Breaks Instantly
Clinician trust in an AI system is built case by case, across months of interaction. A physician who has seen your model flag 50 true positives and generate 3 false positives starts to develop an intuition for when to trust it and when to override it. That calibrated trust is the condition under which AI actually improves clinical decisions. But one high-profile failure — a missed diagnosis, a flagged contraindication that was wrong, an alert at the wrong moment — can destroy months of trust accumulation. Design your product to fail gracefully: when uncertain, say so. When wrong, make it easy for the clinician to override and easy for your team to learn from. The worst thing an AI product can do in healthcare is be confidently wrong.